Spellman David A Insider Trades

Insider Trading History

Track insider trading activity for Spellman David A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $433k 446,483 shares
Last Trade
May 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$68k 63,567 shares
$1.07
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $495k 510,860 shares
Last Trade
Mar 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.34k 7,210 shares
$0.88
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $502k 517,260 shares
Last Trade
Feb 27, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.11k 7,539 shares
$0.81
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $509k 524,799 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$309k 490,500 shares
$0.63
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Director, Svp, CFO And Treasurer
Holding Value $319k 328,599 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 400,000 shares
$0.45
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $125k 128,599 shares
Last Trade
Mar 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.74k 803 shares
$2.17
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $67.3k 69,402 shares
Last Trade
Feb 28, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$15.9k 7,400 shares
$2.15
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $218k 225,000 shares
Last Trade
Feb 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$616k 285,000 shares
$2.16
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $194k 200,000 shares
Last Trade
Sep 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$576k 200,000 shares
$2.88
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $74.5k 76,802 shares
Last Trade
Apr 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.69k 790 shares
$3.40
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $75.2k 77,592 shares
Last Trade
Mar 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.4k 7,592 shares
$3.48
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $116k 120,000 shares
Last Trade
Feb 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$657k 190,000 shares
$3.46
$0.97
Akebia Therapeutics
Akebia Therapeutics AKBA
Svp, CFO And Treasurer
Holding Value $272k 280,000 shares
Last Trade
Jun 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.8M 280,000 shares
$13.58
$0.97
Mersana Therapeutics
Mersana Therapeutics MRSN
Chief Financial Officer
Holding Value $2.91M 100,000 shares
Last Trade
Jan 23, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.78M 100,000 shares
$87.75
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Chief Financial Officer
Holding Value $4.36M 150,000 shares
Last Trade
Mar 12, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.4M 150,000 shares
$349.25
$29.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up